Literature DB >> 26499511

A Role for Diminished GABA Transporter Activity in the Cortical Discharge Phenotype of MeCP2-Deficient Mice.

Liang Zhang1,2,3, Robert G Wither4,5, Min Lang2,4,5, Chiping Wu1,4, Elena Sidorova-Darmos4,5, Hristo Netchev4, Catherine B Matolcsy4, Orlando Carter Snead2,3, James H Eubanks2,4,5,6.   

Abstract

Cortical network hyper-excitability is a common phenotype in mouse models lacking the transcriptional regulator methyl-CPG-binding protein 2 (MeCP2). Here, we implicate enhanced GABAB receptor activity stemming from diminished cortical expression of the GABA transporter GAT-1 in the genesis of this network hyper-excitability. We found that administering the activity-dependent GABAB receptor allosteric modulator GS-39783 to female Mecp2(+/-) mice at doses producing no effect in wild-type mice strongly potentiated their basal rates of spontaneous cortical discharge activity. Consistently, administering the GABAB receptor antagonist CGP-35348 significantly decreased basal discharge activity in these mice. Expression analysis revealed that while GABAB or extra-synaptic GABAA receptor prevalence is preserved in the MeCP2-deficient cortex, the expression of GAT-1 is significantly reduced from wild-type levels. This decrease in GAT-1 expression is consequential, as low doses of the GAT-1 inhibitor NO-711 that had no effects in wild-type mice strongly exacerbated cortical discharge activity in female Mecp2(+/-) mice. Taken together, these data indicate that the absence of MeCP2 leads to decreased cortical levels of the GAT-1 GABA transporter, which facilitates cortical network hyper-excitability in MeCP2-deficient mice by increasing the activity of cortical GABAB receptors.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26499511      PMCID: PMC4832024          DOI: 10.1038/npp.2015.323

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  45 in total

Review 1.  GABA transporter heterogeneity: pharmacology and cellular localization.

Authors:  L A Borden
Journal:  Neurochem Int       Date:  1996-10       Impact factor: 3.921

2.  A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome.

Authors:  J Guy; B Hendrich; M Holmes; J E Martin; A Bird
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

3.  Reduced seizure threshold and altered network oscillatory properties in a mouse model of Rett syndrome.

Authors:  F McLeod; R Ganley; L Williams; J Selfridge; A Bird; S R Cobb
Journal:  Neuroscience       Date:  2012-12-10       Impact factor: 3.590

4.  MeCP2 is required for normal development of GABAergic circuits in the thalamus.

Authors:  Zhong-Wei Zhang; Joseph D Zak; Hong Liu
Journal:  J Neurophysiol       Date:  2010-03-03       Impact factor: 2.714

5.  GABAergic synaptic inputs of locus coeruleus neurons in wild-type and Mecp2-null mice.

Authors:  Xin Jin; Ningren Cui; Weiwei Zhong; Xiao-Tao Jin; Chun Jiang
Journal:  Am J Physiol Cell Physiol       Date:  2013-02-07       Impact factor: 4.249

6.  Defective body-weight regulation, motor control and abnormal social interactions in Mecp2 hypomorphic mice.

Authors:  Bredford Kerr; Matías Alvarez-Saavedra; Mauricio A Sáez; Alexandra Saona; Juan I Young
Journal:  Hum Mol Genet       Date:  2008-03-04       Impact factor: 6.150

7.  Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes.

Authors:  Hsiao-Tuan Chao; Hongmei Chen; Rodney C Samaco; Mingshan Xue; Maria Chahrour; Jong Yoo; Jeffrey L Neul; Shiaoching Gong; Hui-Chen Lu; Nathaniel Heintz; Marc Ekker; John L R Rubenstein; Jeffrey L Noebels; Christian Rosenmund; Huda Y Zoghbi
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

8.  Differential expression of sirtuin family members in the developing, adult, and aged rat brain.

Authors:  Elena Sidorova-Darmos; Robert G Wither; Natalya Shulyakova; Carl Fisher; Melanie Ratnam; Michelle Aarts; Lothar Lilge; Philippe P Monnier; James H Eubanks
Journal:  Front Aging Neurosci       Date:  2014-12-18       Impact factor: 5.750

9.  A partial loss of function allele of methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome.

Authors:  Rodney C Samaco; John D Fryer; Jun Ren; Sharyl Fyffe; Hsiao-Tuan Chao; Yaling Sun; John J Greer; Huda Y Zoghbi; Jeffrey L Neul
Journal:  Hum Mol Genet       Date:  2008-03-04       Impact factor: 6.150

Review 10.  Preclinical research in Rett syndrome: setting the foundation for translational success.

Authors:  David M Katz; Joanne E Berger-Sweeney; James H Eubanks; Monica J Justice; Jeffrey L Neul; Lucas Pozzo-Miller; Mary E Blue; Diana Christian; Jacqueline N Crawley; Maurizio Giustetto; Jacky Guy; C James Howell; Miriam Kron; Sacha B Nelson; Rodney C Samaco; Laura R Schaevitz; Coryse St Hillaire-Clarke; Juan L Young; Huda Y Zoghbi; Laura A Mamounas
Journal:  Dis Model Mech       Date:  2012-11       Impact factor: 5.758

View more
  3 in total

Review 1.  Dysregulated cortical synaptic plasticity under methyl-CpG binding protein 2 deficiency and its implication in motor impairments.

Authors:  Wei-Jia Zhang; Ling-Ling Shi; Li Zhang
Journal:  World J Psychiatry       Date:  2022-05-19

Review 2.  Electrophysiological and Behavioral Evidence for Hyper- and Hyposensitivity in Rare Genetic Syndromes Associated with Autism.

Authors:  Anastasia Neklyudova; Kirill Smirnov; Anna Rebreikina; Olga Martynova; Olga Sysoeva
Journal:  Genes (Basel)       Date:  2022-04-11       Impact factor: 4.141

Review 3.  Reviewing Evidence for the Relationship of EEG Abnormalities and RTT Phenotype Paralleled by Insights from Animal Studies.

Authors:  Kirill Smirnov; Tatiana Stroganova; Sophie Molholm; Olga Sysoeva
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.